may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful..

following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)..

"we have to thank the coroner and his office for the work they have done. they have clearly listened to all of the evidence and came to the conclusion the family had all along..

.

.

loading more comments